Related Experiment Videos
A transgenic mouse expressing human CYP4B1 in the liver
1Department of Chemical Biology, Osaka City University Medical School, Asahimachi, Abeno-ku, Osaka, Japan. imaoka@med.osaka-cu.ac.jp
Biochemical and Biophysical Research Communications
|June 9, 2001
Summary
Researchers developed a transgenic mouse model expressing human CYP4B1 protein, demonstrating its catalytic activity in liver microsomes. This model aids in studying chemical toxicity and carcinogenesis related to CYP4B1.
Area of Science:
- Biochemistry
- Toxicology
- Genetics
Background:
- Cytochrome P450 enzymes (CYPs) are crucial for metabolizing xenobiotics.
- Human CYP4B1's specific catalytic functions and toxicological relevance remain incompletely understood.
- Developing models to study human CYP4B1 is essential for understanding chemical carcinogenesis.
Purpose of the Study:
- To establish a functional expression system for human CYP4B1 in vivo and in vitro.
- To characterize the catalytic activities of human CYP4B1, including substrate specificity and metabolic pathways.
- To provide tools for investigating the role of CYP4B1 in chemical toxicity and cancer development.
Main Methods:
- Generation of a transgenic mouse line expressing human CYP4B1 under the control of the human apolipoprotein E (apo E) gene promoter.
- Analysis of hepatic microsomal enzyme activities, including omega-hydroxylation of lauric acid and 2-aminofluorene (2-AF) activation.
- Detection of mutagenic compounds using a umu gene expression assay.
- Expression of a fusion protein of CYP4B1 and NADPH-P450 reductase in yeast for in vitro characterization.
Main Results:
- Transgenic mouse hepatic microsomes exhibited omega-hydroxylation of lauric acid and activated 2-AF to mutagenic compounds, characteristic of CYP4B1 activity.
- These activities were specifically inhibited by CYP4B1 antibody in transgenic mice, but not in control mice.
- The recombinant CYP4B1-NADPH-P450 reductase fusion protein in yeast also demonstrated catalytic activity towards 2-AF and lauric acid.
Conclusions:
- This study reports the first evidence of catalytic activities of human CYP4B1 in a transgenic mouse model.
- The developed transgenic mouse line and recombinant yeast system serve as valuable tools for studying human CYP4B1.
- These systems will facilitate research into the mechanisms of chemical toxicity and carcinogenesis mediated by CYP4B1.